Open Access

Novel bladder preservation therapy for locally invasive bladder cancer: Combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation

  • Authors:
    • Haruhito Azuma
    • Teruo Inamoto
    • Naokazu Ibuki
    • Takanobu Ubai
    • Yatsugu Kotake
    • Kiyoshi Takahara
    • Satoshi Kiyama
    • Hayahito Nomi
    • Hiroshi Uehara
    • Kazumasa Komura
    • Kazuhiro Yamamoto
    • Yoshihumi Narumi
    • Yoji Katsuoka
  • View Affiliations

  • Published online on: October 1, 2010     https://doi.org/10.3892/ijo_00000727
  • Pages: 773-785
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We investigated the effect of balloon-occluded arterial infusion (BOAI) of anticancer agent (cisplatin/gemcitabine), used concomitantly with hemodialysis, which delivers an extremely high concentration of anticancer agent to the site of a tumor without systemic adverse effects, along with concurrent radiation (referred to as the OMC-regimen) in patients with advanced bladder cancer. One hundred and ninety-two patients were assigned to receive either the OMC-regimen (n=96) or total cystectomy (n=96). Patients in the OMC-regimen group who failed to achieve CR underwent cystectomy, or secondary BOAI with an increased amount of CDDP or gemcitabine (1600 mg). The OMC-regimen allowed >89% (69/77) of patients with locally invasive tumors to achieve CR [>70% (70/96) of all patients including those with T4 and N(+) disease]. Most (68/69) of the CR patients were still alive with no evidence of recurrence after a mean follow-up of 161 (range 12-805) weeks. The 5- and 15-year overall survival rates were 91.5 and 81.3% (vs. 59.8% and 40.1% for cystectomy, P<0.0001), respectively. No patients suffered Grade III or more severe toxicities. In contrast, at 5 and 15 years after surgery in the total cystectomy group, about 50 and 60% of patients had suffered disease progression or had died, respectively. The OMC-regimen, a new bladder-preservation strategy for patients with locally invasive bladder cancer, can be curative not only in patients for whom cystectomy is indicated, but also in patients whose condition is not amenable to curative treatment and for whom merely palliative therapy would otherwise seem the only option.

Related Articles

Journal Cover

October 2010
Volume 37 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Azuma H, Inamoto T, Ibuki N, Ubai T, Kotake Y, Takahara K, Kiyama S, Nomi H, Uehara H, Komura K, Komura K, et al: Novel bladder preservation therapy for locally invasive bladder cancer: Combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation. Int J Oncol 37: 773-785, 2010
APA
Azuma, H., Inamoto, T., Ibuki, N., Ubai, T., Kotake, Y., Takahara, K. ... Katsuoka, Y. (2010). Novel bladder preservation therapy for locally invasive bladder cancer: Combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation. International Journal of Oncology, 37, 773-785. https://doi.org/10.3892/ijo_00000727
MLA
Azuma, H., Inamoto, T., Ibuki, N., Ubai, T., Kotake, Y., Takahara, K., Kiyama, S., Nomi, H., Uehara, H., Komura, K., Yamamoto, K., Narumi, Y., Katsuoka, Y."Novel bladder preservation therapy for locally invasive bladder cancer: Combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation". International Journal of Oncology 37.4 (2010): 773-785.
Chicago
Azuma, H., Inamoto, T., Ibuki, N., Ubai, T., Kotake, Y., Takahara, K., Kiyama, S., Nomi, H., Uehara, H., Komura, K., Yamamoto, K., Narumi, Y., Katsuoka, Y."Novel bladder preservation therapy for locally invasive bladder cancer: Combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation". International Journal of Oncology 37, no. 4 (2010): 773-785. https://doi.org/10.3892/ijo_00000727